Cutaneous lymphomas and association to sex hormones.
Male gender is interpreted as a risk factor for developing mycosis fungoides and perhaps other cutaneous and extracutaneous lymphomas. In this review the authors examine epidemiologic, clinical, pathologic, and molecular data in an effort to understand whether and to what extent gender or sex hormones are involved in the pathogenesis of lymphoproliferative disorders.
Wohl
Yonit
Y
Department of Dermatology, Tel Aviv-Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Golan
Haim
H
Brenner
Sarah
S
D002273:Carcinogens / Q000009:adverse effects*; D005260:Female; D012739:Gonadal Steroid Hormones / Q000009:adverse effects* / Q000378:metabolism; D006801:Humans; D015994:Incidence; D016410:Lymphoma, T-Cell, Cutaneous / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D008967:Molecular Biology; D009182:Mycosis Fungoides / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology; D016273:Occupational Exposure / Q000009:adverse effects*; D011379:Prognosis; D012307:Risk Factors; D012737:Sex Factors; D012878:Skin Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology
D002273:Carcinogens; D012739:Gonadal Steroid Hormones